about
Articles in Endocrinology and Metabolism in 2016.The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis.Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Diabetes Drugs and Cardiovascular Safety
@ast
Diabetes Drugs and Cardiovascular Safety
@en
Diabetes Drugs and Cardiovascular Safety
@nl
type
label
Diabetes Drugs and Cardiovascular Safety
@ast
Diabetes Drugs and Cardiovascular Safety
@en
Diabetes Drugs and Cardiovascular Safety
@nl
prefLabel
Diabetes Drugs and Cardiovascular Safety
@ast
Diabetes Drugs and Cardiovascular Safety
@en
Diabetes Drugs and Cardiovascular Safety
@nl
P2860
P3181
P1476
Diabetes Drugs and Cardiovascular Safety
@en
P2093
Ji Cheol Bae
P2860
P304
P3181
P356
10.3803/ENM.2016.31.2.239
P407
P50
P577
2016-06-10T00:00:00Z